JOHANNESBURG: South African Test cricketer Zubayr Hamza has been provisionally suspended by the International Cricket Council (ICC) under its anti-doping code after testing positive for a prohibited substance, the cricket governing body said on Friday.

Cricket South Africa (CSA) said earlier this week that Hamza, who was left out of the squad for the series against Bangladesh, did not dispute the positive test and agreed to a voluntary suspension.

“Hamza has been charged with the presence and/or use of a prohibited substance following the detection of Furosemide in a sample collected out-of-competition on 17 January 2022,” the ICC said.

Furosemide, a medicine used to treat high blood pressure, heart failure and a build up of fluid in the body, is on the World Anti-Doping Agency’s Prohibited List as a diuretic or masking agent.

CSA said Furosemide is not a performance enhancing substance.

The 26-year-old batter, who has played six Tests for South Africa, is suspended pending the outcome of the disciplinary process.

South Africa host Bangladesh in a two-Test series starting on March 31.

Published in Dawn, March 26th, 2022

Editorial

Updated 04 Aug, 2026

Swat bombing

IT is a bitter irony that terrorists struck a protest against violence in Swat on Sunday, causing at least 17...
04 Aug, 2026

Tariff blow

FOR an export sector already squeezed by high production costs, the additional 10pc tariff on top of the existing...
04 Aug, 2026

Perilous peaks

THE deaths of 10 climbers in an avalanche on Broad Peak is a sad reminder of the perils that many mountaineers face...
Updated 03 Aug, 2026

Farewell to arms?

PALESTINIAN resistance group Hamas recently made a major concession by agreeing to give up its weapons. It should be...
03 Aug, 2026

Unplanned future

A PROJECTION that Pakistan’s population could reach 400m by 2040 should not be treated as another dramatic number...
03 Aug, 2026

No more torture

EVEN the best laws on the books are worth little unless the state shows the willingness to enforce them. This is...